Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/271,880external-prioritypatent/US5693535A/en
Application filed by IndividualfiledCriticalIndividual
Publication of CA2168566A1publicationCriticalpatent/CA2168566A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Molécule d'acide nucléique enzymatique effectuant le clivage d'un ARN du virus de l'immunodéficience dans un gène nécessaire à la réplication virale, par exemple les régions du gène nef ou tat.
CA 21685661993-08-061994-08-04Methode et reactif provoquant l'inhibition de la replication du virus de l'immunodeficience humaine
AbandonedCA2168566A1
(fr)